Journal article
Aspirin for the Prevention of Recurrent Venous Thromboembolism
Abstract
BACKGROUND: In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent VTE remains high after anticoagulant treatment is discontinued. The Aspirin for the Prevention of Recurrent Venous Thromboembolism (the Warfarin and Aspirin [WARFASA]) and the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trials showed that aspirin reduces this risk, but they were not individually powered to detect treatment effects …
Authors
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA
Journal
Circulation, Vol. 130, No. 13, pp. 1062–1071
Publisher
Wolters Kluwer
Publication Date
September 23, 2014
DOI
10.1161/circulationaha.114.008828
ISSN
0009-7322